CD274 and neoplasm: These observations suggest that antigen presentation capabilities are enhanced in the immunosuppressive HNSCC tumor microenvironment following dual PI3Kγ/PD-L1 inhibition, potentially overcoming the typically low immunogenicity of these tumors.